(VIANEWS) – Trip.com (TCOM), First Solar (FSLR), Neurocrine Biosciences (NBIX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Trip.com (TCOM)

38.5% sales growth and 3.74% return on equity

Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally.

Trip.com’s sales growth this year is anticipated to be 29.4% and 48.3% for next year.

Year-on-year quarterly revenue growth declined by 13.2%, now sitting on 17.69B for the twelve trailing months.

Volume

Today’s last reported volume for Trip.com is 2275120 which is 58.18% below its average volume of 5440930.

Trip.com’s sales growth for the next quarter is 38.5%. The company’s growth estimates for the present quarter and the next is 120.7% and negative -33.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.

Volatility

Trip.com’s last day, last week, and last month’s current intraday variation average was 1.84%, 1.58%, and 4.17%, respectively.

Trip.com’s highest amplitude of average volatility was 4.71% (day), 3.93% (last week), and 5.31% (last month), respectively.

Trip.com’s Stock Yearly Top and Bottom Value

Trip.com’s stock is valued at $23.67 at 05:22 EST, way under its 52-week high of $45.19 and higher than its 52-week low of $23.61.

Trip.com’s Moving Average

Trip.com’s value is way under its 50-day moving average of $29.64 and way below its 200-day moving average of $33.27.

2. First Solar (FSLR)

34.6% sales growth and 9.52% return on equity

First Solar, Inc. provides photovoltaic (PV) solar energy solutions in the United State, Japan, France, Canada, India, Australia, and internationally.

First Solar’s sales growth this year is anticipated to be 8.1% and a negative 5.7% for next year.

Year-on-year quarterly revenue growth grew by 51%, now sitting on 2.98B for the twelve trailing months.

Volume

Today’s last reported volume for First Solar is 2941160 which is 72.6% above its average volume of 1704000.

First Solar’s sales growth is a negative 0% for the present quarter and 34.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 56.6% and negative -19.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.

Volatility

First Solar’s last day, last week, and last month’s current intraday variation average was 8.63%, 3.43%, and 2.14%, respectively.

First Solar’s highest amplitude of average volatility was 3.80% (day), 5.26% (last week), and 5.22% (last month), respectively.

First Solar’s Stock Yearly Top and Bottom Value

First Solar’s stock is valued at $85.76 at 05:22 EST, way below its 52-week high of $123.13 and way higher than its 52-week low of $67.71.

First Solar’s Moving Average

First Solar’s worth is way under its 50-day moving average of $106.01 and below its 200-day moving average of $90.95.

3. Neurocrine Biosciences (NBIX)

31.4% sales growth and 41.37% return on equity

Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders.

Neurocrine Biosciences’s sales growth this year is anticipated to be 9% and 22.5% for next year.

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 1.07B for the twelve trailing months.

Volume

Today’s last reported volume for Neurocrine Biosciences is 540548 which is 30.42% below its average volume of 776949.

Neurocrine Biosciences’s sales growth for the next quarter is 31.4%. The company’s growth estimates for the ongoing quarter and the next is a negative 83.5% and 42.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.37%.

Volatility

Neurocrine Biosciences’s last day, last week, and last month’s current intraday variation average was 0.28%, 1.09%, and 1.67%, respectively.

Neurocrine Biosciences’s highest amplitude of average volatility was 2.01% (day), 3.57% (last week), and 3.91% (last month), respectively.

Neurocrine Biosciences’s Stock Yearly Top and Bottom Value

Neurocrine Biosciences’s stock is valued at $84.91 at 05:22 EST, way under its 52-week high of $120.27 and higher than its 52-week low of $78.31.

Neurocrine Biosciences’s Moving Average

Neurocrine Biosciences’s value is under its 50-day moving average of $91.56 and way below its 200-day moving average of $94.42.

4. Columbia Sportswear Company (COLM)

25.4% sales growth and 16.26% return on equity

Columbia Sportswear Company, together with its subsidiaries, designs, sources, markets, and distributes outdoor, active, and everyday lifestyle apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada.

Columbia Sportswear Company’s sales growth this year is expected to be 22.5% and 14.9% for next year.

Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 2.91B for the twelve trailing months.

Volume

Today’s last reported volume for Columbia Sportswear Company is 532592 which is 98.08% above its average volume of 268877.

Columbia Sportswear Company’s sales growth for the next quarter is 25.4%. The company’s growth estimates for the current quarter and the next is 23.6% and 15.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.26%.

Volatility

Columbia Sportswear Company’s last day, last week, and last month’s current intraday variation average was 1.09%, 1.64%, and 1.35%, respectively.

Columbia Sportswear Company’s highest amplitude of average volatility was 2.64% (day), 2.37% (last week), and 2.40% (last month), respectively.

Columbia Sportswear Company’s Stock Yearly Top and Bottom Value

Columbia Sportswear Company’s stock is valued at $94.64 at 05:22 EST, way below its 52-week high of $114.98 and way above its 52-week low of $84.19.

Columbia Sportswear Company’s Moving Average

Columbia Sportswear Company’s value is below its 50-day moving average of $100.67 and below its 200-day moving average of $102.38.

5. PGT (PGTI)

25.3% sales growth and 5.54% return on equity

PGT Innovations, Inc., together with its subsidiaries, manufactures and supplies impact-resistant residential windows and doors in the Southeastern United States, Western United States, the Gulf Coast, Coastal mid-Atlantic, the Caribbean, Central America, and Canada.

PGT’s sales growth this year is anticipated to be 31.2% and 19.6% for next year.

Year-on-year quarterly revenue growth grew by 26.2%, now sitting on 1.08B for the twelve trailing months.

Volume

Today’s last reported volume for PGT is 165865 which is 35.26% below its average volume of 256207.

PGT’s sales growth for the next quarter is 25.3%. The company’s growth estimates for the ongoing quarter and the next is 61.1% and 37%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.54%.

Volatility

PGT’s last day, last week, and last month’s current intraday variation average was 3.11%, 3.29%, and 2.06%, respectively.

PGT’s highest amplitude of average volatility was 3.39% (day), 4.20% (last week), and 3.28% (last month), respectively.

PGT’s Stock Yearly Top and Bottom Value

PGT’s stock is valued at $22.20 at 05:22 EST, way under its 52-week high of $28.11 and way above its 52-week low of $18.81.

PGT’s Moving Average

PGT’s worth is higher than its 50-day moving average of $21.47 and below its 200-day moving average of $22.71.

6. SciPlay Corporation (SCPL)

8% sales growth and 33.79% return on equity

SciPlay Corporation develops, markets, and operates a portfolio of social games for mobile and web platforms worldwide.

SciPlay Corporation’s sales growth this year is expected to be 6.2% and 4% for next year.

Year-on-year quarterly revenue growth declined by 7%, now sitting on 603.4M for the twelve trailing months.

Volume

Today’s last reported volume for SciPlay Corporation is 5234840 which is 720.75% above its average volume of 637809.

SciPlay Corporation’s sales growth for the next quarter is 8%. The company’s growth estimates for the present quarter and the next is a negative 4.3% and 27.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.79%.

Volatility

SciPlay Corporation’s last day, last week, and last month’s current intraday variation average was 1.99%, 4.98%, and 3.51%, respectively.

SciPlay Corporation’s highest amplitude of average volatility was 3.07% (day), 5.22% (last week), and 5.86% (last month), respectively.

SciPlay Corporation’s Stock Yearly Top and Bottom Value

SciPlay Corporation’s stock is valued at $13.15 at 05:22 EST, way under its 52-week high of $22.29 and higher than its 52-week low of $12.25.

SciPlay Corporation’s Moving Average

SciPlay Corporation’s worth is way below its 50-day moving average of $17.62 and way under its 200-day moving average of $17.55.

LEAVE A REPLY

Please enter your comment!
Please enter your name here